Conversely, the elevated abundance of Fusobacterium nucleatum in CRC patients who relapse after chemotherapy inhibits the GSDME-mediated pyroptosis pathway, increasing resistance to 5-fluorouracil and oxaliplatin [94]. Here, GSDME is linked to colorectal carcinoma.